Search results
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 18 hours agoAbbVie has treated the first subject in the Phase III CERVINO clinical trial of its investigational...
CStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab,...
Benzinga· 5 days agoSugemalimab is expected to become the first anti-PD-L1 monoclonal antibody (mAb) in the world approved in Europe for both first-line squamous and non-squamous ...
New influenza B antibody will help develop universal vaccine: US scientists
Investing.com· 5 days agoNew Delhi, June 2 (IANS) US scientists have isolated human monoclonal antibodies against influenza...
After key rare disease win, Annexon eyes $144 million raise - San Francisco Business Times
The Business Journals· 1 day agoAnnexon Inc. hopes to sell $125 million of stock following a late-stage clinical trial of a drug...
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 1 day agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
Short bouts of exercise may boost efficacy of some types of cancer treatment
MedicalNewsToday via AOL· 12 hours agoRecent research suggests that short bouts of moderate to intense exercise could boost the efficacy...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 15 hours agoModerna’s respiratory syncytial virus (RSV) vaccine mRESVIA has received US Food and Drug...
Quadruplet Regimens Have Become Standard for Multiple Myeloma
MedPage Today· 7 days agoWhile triplet regimens were once standard for newly diagnosed multiple myeloma, more recent studies...
Stocks making the biggest moves midday: Five Below, Salesforce, Lululemon, Instacart and more
CNBC· 10 hours agoCheck out the companies making headlines in midday trading: Five Below — Shares of Five Below sank...
FibroGen Announces Clinical Trial Supply Agreement with Regeneron Pharmaceuticals to Evaluate...
Benzinga· 3 days agoFibroGen to evaluate FG-3165, an anti-galectin 9 (Gal9) monoclonal antibody (mAb), as monotherapy treatment as well as in combination with LIBTAYO® in patients ...